Company news
Mesoblast Limited news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Mesoblast Update on Valeant Proposal to Cephalon
February 10, 2016
Mesoblast To Acquire Angioblast Systems, 37M Capital Raising
February 10, 2016
Mesoblast Receives $5.8m From Aus Govt For R&D
February 10, 2016
Mesoblast Provides Strategic Update and Q1 Financial Results
February 10, 2016
Mesoblast Lists On Nasdaq
February 10, 2016
Mesoblast Enters into Agreements to Raise A$170million
February 10, 2016
Key US patent granted for treatment of degenerated discs
February 10, 2016
Key US Patent Granted For Heart, Stroke, Vascular Diseases
February 10, 2016
Key USA Patents Increase Commercial Rights and Indications
February 10, 2016
Key Patent Allowed In Japan For Heart Diseases, Stroke
February 10, 2016
Key Mesoblast Patent Claims Upheld in Europe
February 10, 2016
Key Mesenchymal Precursor Cell Patent Granted in Japan
February 10, 2016
Key Manufacturing Agreement with FDA for Phase 3 Trials
February 10, 2016
Improved Survival in Children with GvHD After Cell Therapy
February 10, 2016
Full Japanese Approval For MSC Product
February 10, 2016
FDA Clears Phase 3 Heart Failure Trial
February 10, 2016
FDA clears phase 2 clinical trial for rheumatoid arthritis
February 10, 2016
Fast Track Access To Potential Japan Investment Incentives
February 10, 2016
Diabetic Nephropathy Results To Be Presented At ADA Meeting
February 10, 2016
Circulation Research Publishes AMI Preclinical Trial Results
February 10, 2016
Chronic Low Back Pain Results Presented at NASS
February 10, 2016
CHF Phase 2 Trial Results Published In Circulation Research
February 10, 2016
Celgene And Mesoblast Extend Agreement
February 10, 2016
Celgene And Mesoblast Enter Into Agreement
February 10, 2016
Angioblast Stockholders Approve Acquisition By Mesoblast
February 10, 2016
Calls
The 5 newest of 10 calls. Every call is listed under its year.
- Mesoblast (ASX:MSB) Q4 2026 Earnings Call
Aug 26, 2026
Transcript - Mesoblast (ASX:MSB) Q2 2026 Earnings Call
Feb 26, 2026
Transcript - Mesoblast (ASX:MSB) Q4 2025 Earnings Call
Aug 28, 2025
Transcript - Mesoblast (ASX:MSB) Q2 2025 Earnings Call
Feb 26, 2025
Transcript - Mesoblast (ASX:MSB) Q4 2024 Earnings Call
Aug 28, 2024
Transcript
Decks
The 5 newest of 105 decks. Every deck is listed under its year.
- FY2026 Earnings Presentation
Earnings · 31 slides · Aug 27, 2026
- Q4 2026 Earnings Presentation
Earnings · 85 slides · Aug 27, 2026
- Investor Presentation (June 2026)
Investor deck · 13 slides · Jun 2, 2026
- Investor Day (April 2026)
Investor day · 85 slides · Apr 8, 2026
- H1 FY26 Earnings Presentation
Earnings · 28 slides · Feb 27, 2026